EGFR and breast carcinoma: Tumor edge spiculation is associated with positive ER and PR expression, negative HER2 and Epidermal Growth Factor Receptor (EGFR) expression, and lymph node metastasis (14), and we believe that it is a predictor of HR+/HER2− breast cancer.